ASCO26: RLTs bring the buzz, but commercial and tolerability qualms remain

Friday, June 19, 2026Annabel Kartal AllenView original

RLTs were a hot topic at ASCO 2026, but certain limitations must be addressed to facilitate their widespread use in cancer care.

Read the full article on the original site.